Reported 7 months ago
On June 13, 2024, at 4:10 p.m., Medigen-KY (8466) reached a near-year high in backlog orders, indicating growth in operations, drawing the attention of institutional and medium- to long-term investors who are buying in at key levels. The stock closed at 66.3 NT dollars on the 13th, surging to a new high in nearly four years and surpassing all short-term moving averages. Short-term, weekly, monthly, and quarterly trends are showing upward reversals, with the 9-day KD value steadily crossing higher. With increasing trading volume this week, various short-term technical indicators are displaying a bullish pattern, and a short-term W bottom has formed between 55 and 60 NT dollars. By breaking through the upper neckline on the 13th, the short-term technical indicators have strengthened, indicating continued upside potential and room for stock price growth. Responding to the demand for orders in the North American market and future order planning, an expansion of production capacity in the Tainan plant is planned for June, which is expected to drive business growth in the second half of the year.
Source: YAHOO